Neurotoxicity Research

, Volume 10, Issue 1, pp 57–63 | Cite as

A prospective assessment of porphyrins in autistic disorders: A potential marker for heavy metal exposure

Article

Abstract

Autism was recently associated with a urinary porphyrin pattern indicative of mercury toxicity in a large cohort of French children. The IRB of the Institute for Chronic Illnesses approved the present study. A total of 37 consecutive American patients ( 7 years-old) with autism spectrum disorders (ASDs) (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-DSM IV), born from 1983-1998, that presented to the Genetic Centers of America for outpatient genetic evaluations were prospectively examined for urinary prophryin levels (LabCorp, Inc.) from June 2005-June 2006. Imaging and laboratory testing were conducted on each patient to rule-out other causal factors for their ASDs. As controls, age-, sex-, and race-matched neurotypical ASD siblings were examined. An apparent dose-response effect was observed between autism severity and increased urinary coproporphyrins. Patients with non-chelated autism (2.25-fold, 83% had levels > 2 SD above the control mean) and non-chelated ASDs (2-fold, 58% had levels > 2 SD above the control mean), but not patients with non-chelated pervasive developmental delay-not otherwise specified (PDD-NOS) or Asperger’s disorder (1.4-fold, 46% had levels > 2 SD above the control mean), had significantly increased median cop rop orp hyrin levels versus controls. A significant increase (1.7-fold) in median cop rop orp hyrin levels was observed among non-chelated ASD patients versus chelated ASD patients. Porphyrins should be routinely clinically measured in ASDs, and potential ASD treatments should consider monitoring por phyrin levels. Additional research should be conducted to evaluate the potential role for mercury exposure in some ASDs.

Keywords

Autistic Chelation Developmental Delay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernard S, A Enayati, L Redwood, H Roger and T Binstock (2001) Autism: a novel form of mercury poisoning.Med. Hypotheses 56, 462–471.PubMedCrossRefGoogle Scholar
  2. Bernard S, A Enayati, H Roger, T Binstock and L Redwood (2002) The role of mercury in the pathogenesis of autism.Mol. Psychiatry 7 (Suppl. 2), S42-S43.PubMedCrossRefGoogle Scholar
  3. Blaxill MF, L Redwood and S Bernard (2004) Thimerosal and autism? A plausible hypothesis that should not be dismissed.Med. Hypotheses 62, 788–794.PubMedCrossRefGoogle Scholar
  4. Boris M, A Goldblatt, J Galanko and SJ James (2004) Association of 5,10-methylenetetrathydrofolate reductase (MTHFR) gene polymorphisms with autistic spectrum disorders.J. Am. Phys. Surg. 9, 106–108.Google Scholar
  5. Bowers MA, LD Aicher, HA Davis and JS Woods (1992) Quantitative determination of porphyrins in rat and human urine and evaluation or urinary porphyrin profiles during mercury and lead exposures.J. Lab. Clin. Med. 120, 272–281.PubMedGoogle Scholar
  6. Bradstreet J, DA Geier, JJ Kartzinel, JB Adams and MR Geier (2003) A case-control study of mercury burden in children with autistic spectrum disorders.J. Am. Phys. Surg. 8, 76–79.Google Scholar
  7. Brewster MA (1988) Biomarkers of xenobiotic exposures.Ann. Clin. Lab. Sci. 18, 306–317.PubMedGoogle Scholar
  8. Buyske S, TA Williams, AE Mars, ES Stenroos, SX Ming, R Wang, M Sreenath, MF Factura, C Reddy, GH Lambert and WG Johnson (2006) Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism.BMC Genet. 7(1), 8.PubMedCrossRefGoogle Scholar
  9. Chauhan A and V Chauhan (2006) Oxidative stress in autism.Pathophysiology 13, 171–181.PubMedCrossRefGoogle Scholar
  10. Counter SA, LH Buchanan, F Ortega and G Laurell (2002) Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines.J. Toxicol. Environ. Health 65, 149–163.CrossRefGoogle Scholar
  11. Daniell WE, HL Stockbridge, RF Labbe, JS Woods, KE Anderson, DM Bissell, JR Bloomer, RD Ellefson, MR Moore, CA Pierach, WE Schreiber, A Tefferi and GM Franklin (1997) Environmental chemical exposures and disturbances of heme synthesis.Environ. Health Perspect. 105 (Suppl. 1), 37–53.PubMedCrossRefGoogle Scholar
  12. Eigsti IM and T Shapiro (2003) A systems neuroscience approach to autism: biological, cognitive, and clinical perspectives.Ment. Retard. Dev. Disabil. Res. Rev. 9, 205–215.PubMedCrossRefGoogle Scholar
  13. Environmental Working Group (2004)Overloaded? New Science, New Insights about Mercury and Autism in Susceptible Children (EWG Action Fund, Washington, DC).Google Scholar
  14. Faustman EM, SM Silbernagel, RA Fenske, T Burbacher and RA Ponce (2000) Mechanisms underlying children’s susceptibility to environmental toxicants.Environ. Health Perspect. 108 (Suppl. 1), 13–21.PubMedCrossRefGoogle Scholar
  15. Geier DA and MR Geier (2005) A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.Med. Sci. Monit. 11 (4), CR160-CR170.PubMedGoogle Scholar
  16. Gross U, GF Hoffmann, and MO Doss (2000) Erthropoietic and hepatic porphyries.J. Inhert. Metab. Dis. 23, 641–661.CrossRefGoogle Scholar
  17. Heyer NJ, AC Bittner, D Echeverria and JS Woods (2006) A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production.Toxicol. Lett. 161, 159–166.PubMedCrossRefGoogle Scholar
  18. Holmes AS, MF Blaxill MF and BE Haley (2003) Reduced levels of mercury in first baby haircuts of autistic children.Int. J. Toxicol. 22, 277–285.PubMedCrossRefGoogle Scholar
  19. James SJ, P Culter, S Melnyk, S Jernigan, L Janak, DW Gaylor, and JA Neubrander (2004) Impaired methylation capacity and increased oxidative stress in children with autism: metabolic biomarkers and genetic predisposition.Am. J. Clin. Nutr. 80, 1611–1617.PubMedGoogle Scholar
  20. James SJ, W Slikker, S Melnyk, E New, M Pogribna and S Jernigan (2005) Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors.Neurotoxicol-ogy 26, 1–8.CrossRefGoogle Scholar
  21. McGinnis WR (2004) Oxidative stress in autism.Altern. Ther. Health Med. 10, 22–36.PubMedGoogle Scholar
  22. Mutter J, J Naumann, R Schneider, H Walach and B Haley (2005) Mercury and autism: accelerating evidence?Neuro. Endocrinol. Lett. 26, 439–446.PubMedGoogle Scholar
  23. Nataf R, C Skorupka, L Amet, A Lam, A Springbett and R Lathe (2006) Porphyinuria in childhood autistic disorder: implications for environmental toxicity.Toxicol. Appl. Pharmcol. 214, 99–108.CrossRefGoogle Scholar
  24. Palmer RF, S Blanchard, Z Stein, D Mandell and C Miller (2006) Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas.Health Place 12, 203–209.PubMedCrossRefGoogle Scholar
  25. Pingree SD, PL Simmonds, KT Rummel and JS Woods (2001) Quantitative evaluation of urinary porphryins as a measure of kidney mercury content and mercury body burden during prolonged methlmercury exposure in rats.Toxicol. Sci. 61, 234–240.PubMedCrossRefGoogle Scholar
  26. Redwood L, S Bernard and D Brown (2001) Predicted mercury concentrations in hair from infant immunizations: cause for concern.Neurotoxicology 22, 691–697.PubMedCrossRefGoogle Scholar
  27. Rosen JF and ME Markowitz (1993) Trends in the management of childhood lead poisonings.Neurotoxicology 14, 211–217.PubMedGoogle Scholar
  28. Sarkany RP (1999) Porphyria. From Sir Walter Raleigh to molecular biology.Adv. Exp. Med. Biol. 455, 235–241.PubMedGoogle Scholar
  29. Serajee FJ, R Nabi, H Zhong and M Hug (2004) Polymorphisms in xenobiotic metabolism genes and autism.J. Child Neurol. 19, 413–417.PubMedGoogle Scholar
  30. Werner E and G Dawson (2005) Validation of the phenomenon of autistic regression using home videotapes.Arch. Gen. Psychiatry 62, 889–895.PubMedCrossRefGoogle Scholar
  31. Windham GC, L Zhang, R Gunier, LA Croen and JK Grether (in press) Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area.Environ. Health Perspect.Google Scholar
  32. Woods JS (1996) Altered prophyrin metabolism as a biomarker of mercury exposure and toxicity.Can. J. Physiol. Pharmacol. 74, 210–215.PubMedCrossRefGoogle Scholar
  33. Woods JS and RM Kardish (1983) Developmental aspects of hepatic heme biosynthetic capability and hematotoxicity-II. Studies on uroporphyrinogen decarboxylase.Biochem. Pharmacol. 32, 73–78.PubMedCrossRefGoogle Scholar
  34. Woods JS and HS Miller (1993) Quantitative measurement of porphyrins in biological tissues and evaluation of tissue porphyrins during toxicant exposures.Fundam. Appl. Toxicol. 21, 291–297.PubMedCrossRefGoogle Scholar
  35. Woods JS, D Echeverria, NJ Heyer, PL Simmonds, J Wilkerson and FM Farin (2005) The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans.Toxicol. Appl. Pharmacol. 206, 113–120.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  1. 1.The Institute for Chronic IllnessesSilver SpringUSA
  2. 2.The Genetic Centers of AmericaSilver SpringUSA

Personalised recommendations